Medico Remedies Limited (NSE:MEDICO)

Market Cap	3.23B -1.3%
Revenue (ttm)	2.06B +36.7%
Net Income	131.15M +29.9%
EPS	1.58 +29.9%
Shares Out	n/a
PE Ratio	24.63
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	20,873
Open	38.62
Previous Close	38.62
Day's Range	37.60 - 38.87
52-Week Range	30.22 - 56.88
Beta	0.60
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 7, 2026

About Medico Remedies

Medico Remedies Limited develops, manufactures, and sells pharmaceutical and nutraceutical products in India. The company offers antibiotics and anti-infectives; beta-lactams-penicillins and cephalosporins; antifungals; vitamins and supplements; cardiovascular products; antipyretic, analgesic, and NSAIDs medicines; antacid and anti-ulcer drugs; antidepressants, antipsychotics, and anti-epileptics; antimalarials; dry syrups; ointments and creams; anti-diabetics; syrups; and miscellaneous products, as well as diuretics, antireterovirals, and ster...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1994
• Employees: 213
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: MEDICO

Financial Performance

In fiscal year 2026, Medico Remedies's revenue was 2.06 billion, an increase of 36.73% compared to the previous year's 1.51 billion. Earnings were 131.15 million, an increase of 29.94%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 22, 2026

Data Sources Report a data error